TY - JOUR
T1 - Underdetection of interstitial lung disease in juvenile systemic sclerosis
AU - Foeldvari, Ivan
AU - Klotsche, Jens
AU - Hinrichs, Bernd
AU - Helmus, Nicola
AU - Kasapcopur, Ozgur
AU - Adrovic, Amra
AU - Sztajnbok, Flavio
AU - Terreri, Maria Teresa
AU - Anton, Jordi
AU - Smith, Vanessa
AU - Katsicas, Maria
AU - Kostik, Mikhail
AU - Vasquez‐Canizares, Natalia
AU - Avcin, Tadej
AU - Feldman, Brian
AU - Janarthanan, Mahesh
AU - Santos, Maria Jose
AU - Sawhney, Sujata
AU - Schonenberg‐Meinema, Dieneke
AU - Sifuentes‐Giraldo, Walter‐Alberto
AU - Alexeeva, Ekaterina
AU - Appenzeller, Simone
AU - Battagliotti, Cristina
AU - Berntson, Lillemor
AU - Bica, Blanca
AU - Costa Reis, Patrícia
AU - Eleftheriou, Despina
AU - Kallinich, Tilmann
AU - Lehman, Thomas
AU - Marrani, Edoardo
AU - Minden, Kirsten
AU - Nielsen, Susan
AU - Nuruzzaman, Farzana
AU - Patwardhan, Anjali
AU - Khubchandani, Raju
AU - Stanevicha, Valda
AU - Uziel, Yosef
AU - Torok, Kathryn S.
N1 - Funding Information:
The inception cohort project was supported by an unrestricted grant from the Joachim Herz Foundation.
Publisher Copyright:
© 2020 American College of Rheumatology.
PY - 2022/3
Y1 - 2022/3
N2 - Objective: Utilizing data obtained from a prospective, international, juvenile systemic sclerosis (SSc) cohort, the present study was undertaken to determine if pulmonary screening with forced vital capacity (FVC) and diffusing capacity for carbon monoxide (DLco) is sufficient to assess the presence of interstitial lung disease (ILD) in comparison to high-resolution computed tomography (HRCT) in juvenile SSc. Methods: The juvenile SSc cohort database was queried for patients enrolled from January 2008 to January 2020 with recorded pulmonary function tests (PFTs) parameters and HRCT to determine the discriminatory properties of PFT parameters, FVC, and DLco in detecting ILD. Results: Eighty-six juvenile SSc patients had both computed tomography imaging and FVC values for direct comparison. Using findings on HRCT as the standard measure of ILD presence, the sensitivity of FVC in detecting ILD in juvenile SSc was only 40%, the specificity was 77%, and area under the curve (AUC) was 0.58. Fifty-eight juvenile SSc patients had both CT imaging and DLco values for comparison. The sensitivity of DLco in detecting ILD was 76%, the specificity was 70%, and AUC was 0.73. Conclusion: The performance of PFTs in juvenile SSc to detect underlying ILD was quite limited. Specifically, the FVC, which is one of the main clinical parameters in adult SSc to detect and monitor ILD, would miss ~60% of children who had ILD changes on their accompanying HRCT. The DLco was more sensitive in detecting potential abnormalities on HRCT, but with less specificity than the FVC. These results support the use of HRCT in tandem with PFTs for the screening of ILD in juvenile SSc.
AB - Objective: Utilizing data obtained from a prospective, international, juvenile systemic sclerosis (SSc) cohort, the present study was undertaken to determine if pulmonary screening with forced vital capacity (FVC) and diffusing capacity for carbon monoxide (DLco) is sufficient to assess the presence of interstitial lung disease (ILD) in comparison to high-resolution computed tomography (HRCT) in juvenile SSc. Methods: The juvenile SSc cohort database was queried for patients enrolled from January 2008 to January 2020 with recorded pulmonary function tests (PFTs) parameters and HRCT to determine the discriminatory properties of PFT parameters, FVC, and DLco in detecting ILD. Results: Eighty-six juvenile SSc patients had both computed tomography imaging and FVC values for direct comparison. Using findings on HRCT as the standard measure of ILD presence, the sensitivity of FVC in detecting ILD in juvenile SSc was only 40%, the specificity was 77%, and area under the curve (AUC) was 0.58. Fifty-eight juvenile SSc patients had both CT imaging and DLco values for comparison. The sensitivity of DLco in detecting ILD was 76%, the specificity was 70%, and AUC was 0.73. Conclusion: The performance of PFTs in juvenile SSc to detect underlying ILD was quite limited. Specifically, the FVC, which is one of the main clinical parameters in adult SSc to detect and monitor ILD, would miss ~60% of children who had ILD changes on their accompanying HRCT. The DLco was more sensitive in detecting potential abnormalities on HRCT, but with less specificity than the FVC. These results support the use of HRCT in tandem with PFTs for the screening of ILD in juvenile SSc.
UR - http://www.scopus.com/inward/record.url?scp=85125040893&partnerID=8YFLogxK
U2 - 10.1002/acr.24499
DO - 10.1002/acr.24499
M3 - Article
SN - 2151-464X
VL - 74
SP - 364
EP - 370
JO - Arthritis Care and Research
JF - Arthritis Care and Research
IS - 3
ER -